This MedLibrary.org supplementary page on Rabson-Mendenhall syndrome is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Rabson-Mendenhall syndrome Classification and external resources |
|
| OMIM | 262190 |
|---|---|
Rabson-Mendenhall syndrome is a rare insulin receptor disorder[1] characterized by severe insulin resistance, developmental abnormalities, and acanthosis nigricans.[2] A hypertrophic pineal gland has been reported in some cases.[3]
Contents |
Clinical presentation
Rabson and Mendenhall described 3 siblings (2 girls, 1 boy) who initially presented with dental and skin abnormalities, abdominal distention, and phallic enlargement.[4] The children demonstrated early dentition, a coarse, senile-appearing facies, and striking hirsutism. An "adult growth of hair of head" at 5 years of age was pictured in the case of one of the girls. In the older girl the genitalia were large enough at the age of 6 months to permit vaginal examination for diagnosis of a left ovarian tumor which was removed soon afterward. The children were mentally precocious. Prognathism and very thick fingernails as well as acanthosis nigricans were also described. Insulin-resistant diabetes developed, and the patients died during childhood of ketoacidosis and intercurrent infections. At necropsy pineal hyperplasia was found in all three.[4]
Biologically, infants display fasting hypoglycemia, postprandial hyperglycemia and hyperinsulinemia, which progress to permanent hyperglycemia and recurrent diabetic ketoacidosis.
Pathophysiology
The condition is transmitted as an autosomal recessive trait, and often affects children of consanguineous parents.[3]
As in leprechaunism, of which Rabson-Mendenhall syndrome represents less severe form, the condition is caused by molecular modification of both alleles of the insulin-receptor gene.
Treatment
Treatment of Rabson-Mendenhall syndrome with pharmacologic doses of human leptin may result in improvement of fasting hyperglycemia, hyperinsulinemia, basal glucose, and glucose and insulin tolerance.[5]
References
- ^ Kasuga M, Kadowaki T (1994). "Insulin receptor disorders in Japan". Diabetes Res Clin Pract. 24 (Suppl.): 145–151. doi:. PMID 7859597.
- ^ "Rabson-Mendenhall Syndrome". WebMD.com. Retrieved on 2007-03-17.
- ^ a b "Rabson-Mendenhall syndrome". orpha.net. Retrieved on 2007-03-17.
- ^ a b Rabson S, Mendenhall E (1956). "Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus; report of 3 cases". Am J Clin Pathol 26 (3): 283–90. PMID 13302174.
- ^ Cochran E, Young J, Sebring N, DePaoli A, Oral E, Gorden P (2004). "Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome". J Clin Endocrinol Metab 89 (4): 1548–54. doi:. PMID 15070911.
|
||||||||||||||
Wikipedia content modification information:
- This page was last modified on 16 June 2008, at 08:00.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Rabson-Mendenhall syndrome".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.